Asymmetric total synthesis of (-)-azaspirene, a novel angiogenesis inhibitor

Journal of the American Chemical Society

Volumn 124, Issue 41, 2002, Pages 12078-12079

  Hayashi, Yujiro ^a   Shoji, Mitsuru ^a   Yamaguchi, Junichiro ^a   Sato, Kenji ^a   Yamaguchi, Shinpei ^a   Mukaiyama, Takasuke ^a   Sakai, Ken ^a   Asami, Yukihiro ^b   Kakeya, Hideaki ^b   Osada, Hiroyuki ^b  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; AZASPIRENE; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHIRALITY; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; X RAY CRYSTALLOGRAPHY;

EID: 0037120884     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja0276826     Document Type: Article

References (37)

1. (a) Folkman, J. J. Natl. Cancer Inst. 1990, 82, 4.
2. (b) Risau, W. Nature 1997, 386, 671.
3. (c) Klagsbrum, M.; Moses, M. A. Chem. Biol. 1999, 6, R217.
4. (d) Gasparini, G. Drugs 1998, 58, 17.
5. Shoji, M.; Yamaguchi, J.; Kakeya, H.; Osada, H.; Hayashi, Y. Angew. Chem., Int. Ed. 2002, 41, 3192.
6. Kakeya, H.; Onose, R.; Koshino, H.; Yoshida, A.; Kobayashi, K.; Kageyama, S.-I.; Osada, H. J. Am. Chem. Soc. 2002, 124, 3496.
7. Asami, Y.; Kakeya, H.; Onose, R.; Yoshida, A.; Matsuzaki, H.; Osada, H. Org. Lett. 2002, 4, 2845.
8. (a) Bloch, P.; Tamm, C.; Bollinger, P.; Petcher, T. J.; Weber, H. P. Helv. Chim. Acta. 1976, 59, 133.
9. (b) Bloch, P.; Tamm, C. Helv. Chim. Acta 1981, 64, 304.
10. (c) Breitenstein. W.; Chexal, K. K.; Mohr, P.: Tamm, C. Helv. Chim. Acta 1981, 64, 379.
11. (d) Mohr, P.; Tamm, C. Tetrahedron 1981, 37, 201.
12. (e) Dolder, M.; Shao, X.; Tamm, C. Helv. Chim. Acta 1990, 73, 63.
13. (f) Shao, X.; Dolder, M.; Tamm, C. Helv. Chim. Acta 1990, 73, 483.
14. (g) Su, Z.; Tamm, C. Helv. Chim. Acta 1995, 78, 1278.
15. (h) Su, Z.; Tamm, C. Tetrahedron 1995, 51, 11177.
16. (i) Komagata, D.; Fujita, S.; Yamashita, N.; Saito, S.; Morino, T. J. Antibiot. 1996, 49, 958.
17. Ando, O.; Satake, H.; Nakajima, M.; Sato, A.; Nakamura, T.; Kinoshita, T.; Furuya, K.; Haneishi, T. J. Antibiot. 1991, 44, 382.
18. Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K.-S.; Kwong, H.-L.; Morikawa, K.; Wang, Z.-M.; Xu, D.; Zhang, X.-L. J. Org. Chem. 1992, 57, 2768.
19. For the determination of ee, see the Supporting Information.
20. Allen, C. F. H.; Endens, C. O., Jr. Organic Syntheses; Wiley & Sons: New York, 1973; Collect. Vol. 3, p 731.
21. Ketene silyl acetal 7 was obtained as a single isomer, the geometry of which has not been determined.
22. 3 is an effective Lewis acid in Mukaiyama aldol reaction of a silylketene acetal derived from di-tert-butyl-(2S,3S)-1,4-dioxaspiro-[4.4]nonane-2,3-dicarboxylate. Evans, D. A.; Barrow, J. C.; Leighton, J. L.; Robichaud, A. J.; Sefkow, M. J. Am. Chem. Soc. 1994, 116, 12111; Evans, D. A.; Trotter, B. W.; Barrow, J. C. Tetrahedron 1997, 53, 8779.
23. 3 is an effective Lewis acid in Mukaiyama aldol reaction of a silylketene acetal derived from di-tert-butyl-(2S,3S)- 1,4-dioxaspiro-[4.4]nonane-2,3-dicarboxylate. Evans, D. A.; Barrow, J. C.; Leighton, J. L.; Robichaud, A. J.; Sefkow, M. J. Am. Chem. Soc. 1994, 116, 12111; Evans, D. A.; Trotter, B. W.; Barrow, J. C. Tetrahedron 1997, 53, 8779.
24. 2 as an effective Lewis acid, see: (a) Fujisawa, H.; Sasaki, Y.; Mukaiyama, T. Chem. Lett. 2001, 190.(b) Evans, D. A.; Tedrow, J. S.; Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc. 2002, 124, 392. (c) Sibi, M. P.; Sausker, J. B. J. Am. Chem. Soc. 2002, 124, 984.
25. (a) Fujisawa, H.; Sasaki, Y.; Mukaiyama, T. Chem. Lett. 2001, 190.(b) Evans, D. A.; Tedrow, J. S.; Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc. 2002, 124, 392. (c) Sibi, M. P.; Sausker, J. B. J. Am. Chem. Soc. 2002, 124, 984.
26. (a) Fujisawa, H.; Sasaki, Y.; Mukaiyama, T. Chem. Lett. 2001, 190.(b) Evans, D. A.; Tedrow, J. S.; Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc. 2002, 124, 392. (c) Sibi, M. P.; Sausker, J. B. J. Am. Chem. Soc. 2002, 124, 984.
27. 3, Z = 2 R1 = 0.0698 for 1 > 2.0σ, wR2 = 0.1713 for all data (5002 reflections). The details are supplied as Supporting Information (Figure SI).
28. The geometry of the olefins was determined by NOESY experiment.
29. (a) Koseki, Y.; Kusano, S.; Ichi, D.; Yoshida, K.; Nagasaka, T. Tetrahedron 2000, 56, 8855.
30. (b) Cid, M. M.; Dominguez, D. D.; Castedo, L.; Vazquez-Lopez, E. M. Tetrahedron 1999, 55, 5599.
31. (a) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155.
32. (b) Dess, D. D. B.; Martin, J. C. J. Am. Chem. Soc. 1991, 113, 7277.
33. Ireland, R. E.; Liu, L. J. Org. Chem. 1993, 58, 2899.
34. Meyer, S. D.; Schreiber, S. L. J. Org. Chem. 1994, 59, 7549.
35. 13C NMR analyses show that 15 exists in the 1,3-diketo form rather than the keto-enol form.
36. The stereochemistry at C8 was confirmed by NOESY and difference NOE experiments, see Supporting Information.
37. 16 was obtained in 94% yield from 15 by repeated treatment with thin-layer chromatography (TLC).